Trial intelligence / Profile preview

PREMAL: DP for Malaria Prophylaxis in Forest Rangers

NCT02788864Phase 4Completed

Sponsor
Oxford University Clinical Research Unit
Start
May 2016
Primary completion
Nov 2016
Modality
Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of dihydroartemisinin + piperaquine in malaria, sponsored by Oxford University Clinical Research Unit. Started May 2016; status: completed.

02

Drugs

dihydroartemisinin + piperaquine
03

Conditions

malaria

Beyond the preview

Go deeper on NCT02788864.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02788864.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call